Target Selection
Identify scalable, innovative businesses in hottest sectors
Equity Participation
Acquire 5–15% ownership through structured SPVs.
Value Creation
Provide capital, investor relations support, and strategic guidance to prepare for IPO or uplisting.
Strategy
Exit Plan
Monetize positions post-IPO within 1–2 years, targeting superior risk-adjusted returns.
Amistat
Capital Partners
Amistat Capital Partners is a boutique investment firm specializing in alternative investments in the US public markets (NASDAQ / NYSE).

Through dedicated SPVs, we partner with high-potential companies, acquiring 5–15% equity stakes and guiding them to a successful public listing within 12-18 months.
Investment criteria
Business type
Target Profile
Business sectors
  • Emerging growth and industry
  • Innovative and scalable business domain
  • AI, SaaS, Cybersecurity, Hardware
  • Biotech, Medtech, Longevity
  • Fintech, Martech, Edtech
Cap raise
$5M - $30M
Revenue
(early stage-revenue
in emerging industries)
$3M - $10M
Valuation (cap)
$50M - $250M
Exchanges
Nasdaq/NYSE
Business model
Example of Share Distribution
65%
Company shares
20%
Public offering
8%
Underwrite’s fee
5-15%
Fund’s equity and success fee
1
2
3
4
Comprehensive scoring and multi-level due diligence
Pre-IPO and bridge financing
IPO fundraising of $5-25M
Success fee and equity fee
Our model gives investors unique exposure to late-stage private companies with a clear and timely route to liquidity, capturing value both at pre-IPO entry valuations and through post-IPO equity growth
Managing risks
1
We carefully filter and double-check all companies using open data and modern scoring systems.
2
We initiate activities solely with fully prepared companies, contingent upon commitment from a lead IPO investor and underwriter.
3
100% of investments are covered by liquid equity collateral on the company's side.
Secret sauce
Our investment process will commence only after receiving the underwriter's firm commitment.
Will you take a board seat? How do you approach governance?
Governance is tailored to the situation. We usually request information rights and may take a board observer role. A full board seat is case-by-case. Our aim is constructive oversight that supports the listing process and public-company discipline.
How long does it take to close and to list?
Indicatively, 6–10 weeks from term alignment to closing (timing depends on readiness and jurisdiction). A US listing is generally targeted within 12–18 months, subject to market conditions, audit cadence, and regulator/venue timelines.
What equity stake and structure do you target?
Typically 5–15% minority ownership via a dedicated SPV, with customary minority protections (information rights, vetoes on fundamental actions, pro-rata, and—where appropriate—board observer rights). We do not seek operational control.
Which documents are required for due diligence?
A standard package that includes: corporate/constitutional documents for all entities in the group, cap table (fully diluted), key contracts, financials (Balance Sheet, P&L/Income Statement, Cash Flow, General Ledger, AR/AP aging), tax filings, audit reports (if any), litigation/disputes, IP register, compliance policies, and a detailed use of proceeds.
What types of companies can’t you work with?
We cannot invest in companies based in or controlled from sanctioned jurisdictions. We also do not invest in gambling or crypto businesses. Additional exclusions may apply
case-by-case to meet regulatory and LP requirements
What do you offer apart from financing?
IPO readiness (equity story, comps, financial model), investor relations support, intros to capital markets partners, timeline/venue guidance, media and disclosure prep, and ongoing
buy-side feedback.
What is the process like?
  • Intro & screening: quick fit check on market, metrics, and listing path.
  • Indicative terms: non-binding proposal and alignment on use of proceeds.
  • Confirmatory due diligence: legal/financial/operational review.
  • SPV & closing: final docs, funds flow, governance rights.
  • Go-public prep: equity story, comps, IR materials, timetable, venue selection.
  • Post-close: ongoing support through listing and the initial public phase.
Are you open to all geographies?
We partner with companies globally provided they plan a US listing and meet US regulatory, accounting, and disclosure standards. Local legal and tax considerations must be compatible with our SPV structure.
At what stage do you invest?
Late-stage private companies preparing for a US public listing (NASDAQ/NYSE/OTCQB) or uplisting. We typically work with businesses that can credibly target a listing within 12–18 months
Who should I reach out to?
Please contact our IR team via the website form

(topic: “IR / Capital”) or email info@amistatcapital.com. If you’re fundraising, include a 1-pager, latest metrics, and target timeline.
FAQ
Team
Johann Dechant
General Partner
Johann Dechant is a serial entrepreneur and strategic advisor with extensive experience in digital media, healthcare, SaaS, IT infrastructure, and alternative investments. Johann has been establishing and scaling ventures in healthcare, SaaS, and publishing, as well as co-founding a data center infrastructure provider.

He works with entrepreneurs and investors on product development, strategy, and financial structuring, leveraging a strong network across multiple industries and markets in Europe, the UAE, and emerging regions.

As an angel investor, he has backed ventures such as US Bitcoin, the Hut8 merger, Collective Ace, and Virtex Stadium.
George Zoidze
Managing Partner
George Zoidze is a seasoned professional with more than twenty-five years of experience in the investment, merchant banking, and financial services industries.

Mr. Zoidze served as Chairman and Member of the Supervisory Board of Investbank in the Republic of Georgia. He later co-founded PRIMACAPITAL I.F.C. Ltd., a consulting firm through which he advised on multiple mergers and acquisitions across the European Union in sectors as diverse a telecommunications, information technology, media, and cosmetics.

His expertise has also been sought in senior corporate governance roles, including as CFO and Director of Aurora Acquisition Corp., as well as Director of Accordium Advisory AG, an independent consulting company specializing in SPACs and Capital Pool Companies seeking transactions in the EU. Mr. Zoidze holds a Master’s degree in Economics and a diploma from the Harvard Law School Negotiation Institute.
Ivan Lunegov
Managing Partner
Ivan Lunegov is a capital markets advisor, investor, and entrepreneur with over 15 years of experience. He has participated in more than 160 IPOs as an investor and has personally advised and guided over 25 companies through the IPO process.

Ivan serves on the boards of publicly traded companies and specializes in cross-border listings, corporate governance, and growth strategies for emerging businesses. Throughout his career, he has founded and managed consulting and investment firms focused on helping companies access global capital markets and unlock long-term value.

In addition to his advisory practice, Ivan continues to invest in public companies and support innovative ventures at the intersection of finance and technology.
Leave your email for a readiness review
info@amistatcapital.com
Amistat Capital Partners © 2025 - All Rights Reserved